51: The State of Sleep Medicine

Welcome to the NeurologyLive® Mind Moments™ podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we spoke with Karl Doghramji, MD, professor of psychiatry and human behavior; professor of neurology; and medical director, Jefferson Sleep Disorders Center, at the Vickie and Jack Farber Institute for Neuroscience of Jefferson Health. He shared his perspective on the current state of care for sleep disorders, the impact of the pandemic on sleep in the US, and some of the recent advances in therapeutics and research. Episode Breakdown: 1:15 – The role of sleep in individuals' emotional and physical lives 5:40 – Current awareness about the health effects of poor sleep 8:15 – Clinical and commercial tools to measure sleep 10:45 – Recent advances in therapeutics for sleep disorders 15:20 – Tailoring specific therapies for specific patients 17:15 – Neurology News Minute 19:45 – Narcolepsy as a model for other sleep disorders 22:20 – Patient identification and differential diagnosis 25:40 – The sleep specialist's inclusion in the comprehensive care model 28:25 – Meeting the increasing demand for sleep specialists 30:40 – Sleep's role in dementia and cognition 33:50 – The state of sleep amid the COVID-19 pandemic The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: Phase 3 PHOENIX Study of AMX0035 in ALS Gets Under Way FDA Approves First Oral Solution of Topiramate to Treat Epilepsy, Migraines Robert Califf, MD, Nominated by Biden Administration as Next FDA Commissioner Thanks for listening to the NeurologyLive® Mind Moments™ podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.